Crosstree Capital Partners

Crosstree Capital Partners is a boutique investment banking firm specializing in the health sciences sector. The firm focuses on middle-market companies within pharmaceutical services, diagnostics and tools, and digital health. Since its inception in 2004, Crosstree has advised on more completed transactions in these subsectors than any other investment bank. The firm offers a full suite of advisory and capital raising services, including buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients with the expertise common to a bulge-bracket investment banking firm, tailored to middle-market companies and investors. This specialization offers unparalleled industry insights, well-established strategic relationships across the globe, and superior access to capital markets. From its offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. All securities transactions are offered by and conducted through Crosstree Capital Securities, LLC, a broker-dealer registered with the SEC, a member of FINRA, and SIPC, and an affiliate of Crosstree Capital Partners, Inc.

Middle-market companies in pharmaceutical services, diagnostics and tools, and digital health sectors seeking advisory and capital raising services.